EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Neuroprotection and Beyond: The Central Role of CB1 and CB2 Receptors in Stroke Recovery

Bashir Bietar iD, Sophie Tanner, Christian Lehmann iD

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms242316728 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Bashir Bietar und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Dalhousie University, Halifax, NS B3H 4R2, Canada. Hauptthemen laut MEDLINE: Endocannabinoids, Stroke. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 116 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The endocannabinoid system, with its intricate presence in numerous cells, tissues, and organs, offers a compelling avenue for therapeutic interventions. Central to this system are the cannabinoid receptors 1 and 2 (CB1R and CB2R), whose ubiquity can introduce complexities in targeted treatments due to their wide-ranging physiological influence. Injuries to the central nervous system (CNS), including strokes and traumatic brain injuries, induce localized pro-inflammatory immune responses, termed neuroinflammation. Research has shown that compensatory immunodepression usually follows, and these mechanisms might influence immunity, potentially affecting infection risks in patients. As traditional preventive treatments like antibiotics face challenges, the exploration of immunomodulatory therapies offers a promising alternative. This review delves into the potential neuroprotective roles of the cannabinoid receptors: CB1R’s involvement in mitigating excitotoxicity and CB2R’s dual role in promoting cell survival and anti-inflammatory responses. However, the potential of cannabinoids to reduce neuroinflammation must be weighed against the risk of exacerbating immunodepression. Though the endocannabinoid system promises numerous therapeutic benefits, understanding its multifaceted signaling mechanisms and outcomes remains a challenge.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EndocannabinoidsStrokeHumansNeuroinflammatory DiseasesNeuroprotectionReceptor, Cannabinoid, CB1Receptor, Cannabinoid, CB2Receptors, Cannabinoid

Stichwörter der Autor:innen

CB1 receptorsCB2 receptorsCIDSendocannabinoid systemimmunomodulationneuroinflammationstroke recovery

Substanzen

EndocannabinoidsReceptor, Cannabinoid, CB1Receptor, Cannabinoid, CB2Receptors, CannabinoidCNR2 protein, humanCNR1 protein, human

Autor:innen und Institutionen

  • Department of Pharmacology, Dalhousie University, Halifax, NS B3H 4R2, Canada.
  • Department of Anesthesia, Pain Management, and Perioperative Medicine, Dalhousie University, Halifax, NS B3H 4R2, Canada.

ORCID-Profile: Bashir Bietar, Christian Lehmann

Zitieren

APA

Bietar, B., Tanner, S., & Lehmann, C. (2023). Neuroprotection and Beyond: The Central Role of CB1 and CB2 Receptors in Stroke Recovery. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms242316728

Vancouver

Bietar B, Tanner S, Lehmann C. Neuroprotection and Beyond: The Central Role of CB1 and CB2 Receptors in Stroke Recovery. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms242316728

BibTeX
@article{Bietar2023,
  author = {Bietar, Bashir and Tanner, Sophie and Lehmann, Christian},
  title = {Neuroprotection and Beyond: The Central Role of CB1 and CB2 Receptors in Stroke Recovery},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms242316728}
}
Kostenlos starten →